FDA-cleared profile

SwiftMR

Airs Medical, Inc. · MRI · FDA-cleared (510(k))

Authorized purpose: MRI image enhancement through noise reduction and sharpening; clinicians retain responsibility for final patient management decisions.

Clinical role
Post-processing image enhancement
Images and patients
MRI · Whole Body
Key limitation
Keep in mind: An image-enhancement aid, not a substitute for clinician decisions; not intended for mobile devices. The listed field strengths define the cleared acquisition scope.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: MRI image enhancement through noise reduction and sharpening; clinicians retain responsibility for final patient management decisions.
  • Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Whole Body Input: DICOM MRI of all body parts at 0.25, 0.31, 0.4, 0.55, 0.6, 1.5 and 3.0 T, including images produced by conventional vendor reconstruction or vendor-implemented deep-learning reconstruction.
  • Who uses it?Intended users: Healthcare professionals, including radiology technologists in imaging centers, clinics and hospitals.
  • What does the software produce?Output: Enhanced DICOM MR images returned to PACS or the MRI device; adjustable denoising levels 0-8 and sharpness levels 0-5.
  • What is its most important limitation?Key limitation: An image-enhancement aid, not a substitute for clinician decisions; not intended for mobile devices. The listed field strengths define the cleared acquisition scope.

Clinical takeaway. Clinical role: MRI image enhancement through noise reduction and sharpening; clinicians retain responsibility for final patient management decisions.

Evidence takeaway. Evidence from the reviewed source record: K253775 describes retrospective standalone image-quality validation across adult and pediatric images, body regions, vendors and protocols. Published SwiftMR studies reviewed below are family context, not verified results for version 4.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
MRI image enhancement through noise reduction and sharpening; clinicians retain responsibility for final patient management decisions.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Post-processing image enhancement
  • Exact FDA submission
  • Checked 2026-09-05
Required input
DICOM MRI of all body parts at 0.25, 0.31, 0.4, 0.55, 0.6, 1.5 and 3.0 T, including images produced by conventional vendor reconstruction or vendor-implemented deep-learning reconstruction.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
Enhanced DICOM MR images returned to PACS or the MRI device; adjustable denoising levels 0-8 and sharpness levels 0-5.
  • Exact FDA submission
  • Checked 2026-09-05
Care setting
Adult and pediatric imaging in healthcare facilities.
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Healthcare professionals, including radiology technologists in imaging centers, clinics and hospitals.
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
An image-enhancement aid, not a substitute for clinician decisions; not intended for mobile devices. The listed field strengths define the cleared acquisition scope.
  • Exact FDA submission
  • Checked 2026-09-05
Evidence summary
K253775 describes retrospective standalone image-quality validation across adult and pediatric images, body regions, vendors and protocols. Published SwiftMR studies reviewed below are family context, not verified results for version 4.
  • Exact FDA submission
  • Checked 2026-09-05

Regulatory acceptance thresholds are not reported here as achieved average performance. The public summary does not give a single validation sample total.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K253775 describes retrospective standalone image-quality validation across adult and pediatric images, body regions, vendors and protocols. Published SwiftMR studies reviewed below are family context, not verified results for version 4.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Regulatory acceptance thresholds are not reported here as achieved average performance. The public summary does not give a single validation sample total.

Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

An exact-release disease-detection sensitivity endpoint was not established in the reviewed enhancement validation.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

An exact-release disease-detection specificity endpoint was not established in the reviewed enhancement validation.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K253775 standalone MRI enhancement validation

  • DesignRetrospective standalone image-quality and radiologist evaluation described in the FDA summary
  • PopulationAdult and pediatric MRI across neuro, musculoskeletal and body applications, scanner vendors, protocols and listed field strengths
  • Scopeexact submission
  • Tested versionSwiftMR configuration submitted in K253775
  • IndependenceSponsor or vendor study

K253775

Includes standard and reduced-acquisition images. No clinical-outcome benefit is inferred from image-quality acceptance criteria.

Leveraging a vendor-neutral deep learning reconstruction algorithm to reduce scan time and enhance image quality in T2-weighted liver MRI

  • DesignRetrospective single-center image-quality comparison with two radiologist readers
  • Population86 patients undergoing nonenhanced 3 T liver MRI at Severance Hospital in August 2024
  • Scopeproduct family
  • Tested versionSwiftMR; exact software release not established in the reviewed abstract
  • Samplen=86
  • Sites1
  • IndependenceIndependence not established

PMID:42420358 · DOI:10.1038/s41598-026-60802-5

Compared routine two-breath-hold imaging with SwiftMR one- and two-breath-hold imaging. Improved sharpness/SNR did not eliminate the motion tradeoff; no K253775 linkage is asserted.

Signal-to-noise ratio improvement in postmortem MRI using deep learning reconstruction (SwiftMR)

  • DesignPostmortem head MRI comparison with blinded observer SNR measurements
  • Population33 consecutive postmortem head examinations at 0.3 T
  • Scopeproduct family
  • Tested versionSwiftMR 3.0.11.0
  • Samplen=33
  • IndependenceIndependence not established

PMID:42019274 · DOI:10.1016/j.forsciint.2026.112973

Different software release and forensic population; not evidence of version 4 performance in living patients.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

Downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM MRI of all body parts at 0.25, 0.31, 0.4, 0.55, 0.6, 1.5 and 3.0 T, including images produced by conventional vendor reconstruction or vendor-implemented deep-learning reconstruction.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · SwiftMR: K253775 clearance and 510(k) summary

  2. Routing

    Source context, not route validation: Automatic background DICOM processing with a client for status and administrative settings; enhanced images transfer to PACS or the MRI device.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · SwiftMR: K253775 clearance and 510(k) summary

  3. AI processing

    Source context, not route validation: The current vendor FAQ describes a gateway PC connected to MRI and PACS and discusses cloud deployment.

    Scope: Product family. Current family documentation is not an exact-release hosting or data-processing agreement.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · SwiftMR product and implementation FAQ

  4. Returned objects

    Source context, not route validation: Enhanced DICOM MR images returned to PACS or the MRI device; adjustable denoising levels 0-8 and sharpness levels 0-5.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · SwiftMR: K253775 clearance and 510(k) summary

  5. Viewer/worklist/report

    Unresolved route: Enhanced DICOM MR images returned to PACS or the MRI device; adjustable denoising levels 0-8 and sharpness levels 0-5.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · SwiftMR: K253775 clearance and 510(k) summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The current vendor FAQ describes a gateway PC connected to MRI and PACS and discusses cloud deployment.
  • Product family
  • Checked 2026-09-05

Current family documentation is not an exact-release hosting or data-processing agreement.

Integration
Automatic background DICOM processing with a client for status and administrative settings; enhanced images transfer to PACS or the MRI device.
  • Exact FDA submission
  • Checked 2026-09-05
Security
AIRS Medical's SwiftMR information security white paper summary states security practices for cloud and on-premises workflows (transport encryption, network access control, application security, identity management, backup, disaster recovery, monitoring) and lists ISO/IEC 27001:2022, GDPR, HIPAA and SOC 2 Type II. Vendor statement about SwiftMR; the full white paper was not read.
  • Vendor-wide
  • Checked 2026-10-25

Vendor statement, not an attestation; exact-release scope is not established.

Training
The vendor describes gateway installation, protocol setup on the MR console, user training and monitoring during implementation.
  • Product family
  • Checked 2026-09-05

The advertised implementation schedule is not a site-specific service commitment.

Monitoring
The vendor describes ongoing monitoring of usage and user satisfaction.
  • Product family
  • Checked 2026-09-05

This does not establish clinical drift surveillance or a contracted incident-response service.

DICOM image return

Enhanced DICOM images transfer to PACS or MRI device.

exact submission · checked 2026-09-05

Family implementation workflow

Gateway installation, MR-console protocol setup and user training are described by the vendor.

product family · checked 2026-09-05
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K253775
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
MRI
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Whole Body
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-03-26
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
20Fields reviewed
12Source classes checked
3Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

42420358 and 42019274 retained as family contextual studies after abstract review. 38893725 metadata is relevant to TWIST MRA enhancement, but the live PubMed page did not provide readable content and exact-release linkage remains unresolved; no results promoted. The current discovery snapshot contains 3 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, vendor documentation, fda decision summary, vendor product page, peer reviewed literature, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission

    Reviewed vendor material offers a demo and ROI examples, not a price for the K253775 configuration. A license and implementation quote is needed.

  • Pricing model: Not verified - checked 2026-09-05 - Exact FDA submission

    Per-scanner, per-exam and subscription terms were not established.

  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "SwiftMR AIRS Medical reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

10 sources - 3 history items

Source ledger

  1. SwiftMR: K253775 clearance and 510(k) summary

    U.S. Food and Drug Administration - Accessed 2026-09-05

    Scope: purpose, clinicalUse, modality, anatomy, input, output, limitations, integration, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. SwiftMR model card (K253775)

    American College of Radiology - Published 2026-08-26 - Accessed 2026-09-01

    Scope: purpose, modality, intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Leveraging a vendor-neutral deep learning reconstruction algorithm to reduce scan time and enhance image quality in T2-weighted liver MRI.

    U.S. National Library of Medicine - Accessed 2026-09-04

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  8. Signal-to-noise ratio improvement in postmortem MRI using deep learning reconstruction (SwiftMR).

    U.S. National Library of Medicine - Accessed 2026-09-04

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  9. SwiftMR product and implementation FAQ

    AIRS Medical - Accessed 2026-09-05

    Scope: productFamilyContext, deployment, training, monitoring, implementationCapabilities

  10. AIRS Medical SwiftMR Information Security white paper summary

    AIRS Medical - Accessed 2026-10-25

    Scope: security

Research history

  1. K253775 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K243250

SubtleHD (1.x)

Subtle Medical, Inc.

Authorized purpose: MRI image enhancement through noise reduction and sharpening for clinical image review.

Modality
MRI
Anatomy
Whole Body
Decision
2025-02-12
FDA-cleared K253690

LungMaps

Siemens Healthineers AG

Authorized purpose: LungMaps processes one or more 2D lung MRI time series to support radiologist interpretation of ventilation and perfusion maps; it is not the sole source for diagnosis.

Modality
MRI
Anatomy
Chest/Lung
Decision
2026-06-15
FDA-cleared K260113

uMR Astra

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMR Astra is a diagnostic MR system for cross-sectional and spectroscopic imaging of the labeled head, body, and extremities.

Modality
MRI
Anatomy
Head; body; and extremities
Decision
2026-05-22

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history